Rheumatic polymyalgia is usually treated with medications, including nonsteroidal anti-inflammatory drugs such as diclofenac sodium, glucocorticoids such as prednisone tablets, and immunosuppressants such as methotrexate. Rheumatic polymyalgia is characterized by predominant muscle pain and morning stiffness in the neck, scapular girdle and pelvic girdle, accompanied by fever. The main goals of treatment are to relieve symptoms, control disease progression, and prevent complications. Some patients are self-limiting. Treatment includes NSAIDs, glucocorticoids, and immunosuppressive agents. NSAIDs are more suitable for patients with initial or mild symptoms. Examples include diclofenac and meloxicam. Some patients can relieve symptoms, but most patients have poorer efficacy. Glucocorticoid therapy can significantly improve symptoms, and prednisone is usually given in small doses. As symptoms improve and blood sedimentation approaches normal, tapering can begin. Most patients can stop glucocorticoids within 2 years, and a few patients need to be maintained in small doses for many years. During glucocorticoid therapy, attention should be paid to the adverse effects of the hormones, and blood pressure and blood glucose should be monitored. For glucocorticoid therapy is poor or difficult to reduce the amount of glucocorticoid therapy, there are contraindications, serious adverse reactions, can consider the joint application of immunosuppressive agents. For example, methotrexate, etc. The above drugs must be used in accordance with medical advice. When rheumatic polymyalgia occurs, it is recommended to go to the rheumatology and immunology department in a timely manner, follow the doctor’s instructions to do further examination, and carry out targeted treatment.